Autor según el artículo: Franco, Fernando; Guirado, Maria; Martinez-Banaclocha, Natividad; Guma, Josep; Lavernia, Javier; Gomez-Codina, Jose; Rodriguez-Abreu, Delvys; Martinez, Fani; Barrajon, Enrique; Mendez, Miriam; Calvo, Virginia; Provencio, Mariano
Departamento: Medicina i Cirurgia
Autor/es de la URV: Gumà Padró, José
Palabras clave: Lymphoma Infection of sars-cov-2 Covid-19
Resumen: The new Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) coronavirus has generated a pandemic, in which there are population groups at higher risk and who are potentially fatal victims of the disease. Cancer patients have been considered a group with special susceptibility, particularly patients with lung tumour involvement and haematological neoplasms. The Spanish Lymphoma Oncology Group (GOTEL) carried out a multicenter study of SARS-CoV-2 seroprevalence in patients with lymphoma. Results: A total of 150 patients were included between 22 May and 11 June 2020. The mean age was 65 years (range 17-89), 70 women (46.5%) and 80 men (53, 5%). At the time of diagnosis of lymphoma, 13 cases were stage I (9%), 27 (18%) stage II, 37 (24.5%) stage III, and 73 (48.5%) stage IV, while 6.6% had a primary extranodal origin. A total of 10 cases with positive serology for SARS-CoV-2 were identified, which is a prevalence of 6% in this population. None of the patients required intensive care unit management and all fully recovered from the infection. Conclusion: IgG antibody seroprevalence in lymphoma patients appears similar to that of the general population and does not show greater aggressiveness.
Áreas temáticas: Oncology Medicina i
Acceso a la licencia de uso: https://creativecommons.org/licenses/by/3.0/es/
Direcció de correo del autor: jose.guma@urv.cat
Identificador del autor: 0000-0001-7541-9832
Fecha de alta del registro: 2024-07-27
Versión del articulo depositado: info:eu-repo/semantics/publishedVersion
Enlace a la fuente original: https://www.mdpi.com/1718-7729/28/2/118
URL Documento de licencia: https://repositori.urv.cat/ca/proteccio-de-dades/
Referencia al articulo segun fuente origial: Current Oncology. 28 (2): 1249-1255
Referencia de l'ítem segons les normes APA: Franco, Fernando; Guirado, Maria; Martinez-Banaclocha, Natividad; Guma, Josep; Lavernia, Javier; Gomez-Codina, Jose; Rodriguez-Abreu, Delvys; Martinez (2021). Multicenter Study of the Seroprevalence of Antibodies against Covid-19 in Patients with Lymphoma: An Analysis of the Oncological Group for the Treatment and Study of Lymphomas (Gotel). Current Oncology, 28(2), 1249-1255. DOI: 10.3390/curroncol28020118
DOI del artículo: 10.3390/curroncol28020118
Entidad: Universitat Rovira i Virgili
Año de publicación de la revista: 2021
Tipo de publicación: Journal Publications
Repositori URV